Summary
The sympathetic nerves of the cat spleen were stimulated electrically (20 v, 1 msec, 7 sec) with increasing frequencies (1–30 Hz) during perfusion of the spleen with normal or low-calcium Krebs solution. Noradrenaline (NA) output per stimulus was measured.
In spleens perfused with normal Krebs solution, the NA output per stimulus at 5 Hz was barely detectable, while the output at 30 Hz was about 5-fold greater than at 5 Hz. Reduction of the calcium concentration in the Krebs solution to 0.2–0.5 mM, while reducing outputs at both frequencies, resulted in an output at 30 Hz that was nearly 8 to 10 times that at 5 Hz.
In spleens pretreated with phenoxybenzamine (PBZ) the NA output was increased at all frequencies, and the maximal output occurred at 5 Hz, whereas the output at 30 Hz was only one-third of the maximal output. Reduction of the calcium concentration of the perfusion solution to 0.5 mM, while reducing outputs from PBZ-treated spleens, increased the output at 30 Hz by about 5-fold over the output at 5 Hz.
The muscarinic inhibition of stimulation-evoked release of NA by acetylcholine was much more pronounced at low than at high frequency of stimulation. The increase in the release of NA per stimulus with increase in the frequency of sympathetic nerve stimulation is explained on the assumption that the specific entry of calcium ions required for transmitter release is also frequency-dependent.
References
Anton, A. H., Sayre, D. F.: A study of the factors affecting the aluminium oxidetrihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. exp. Ther. 138, 360–375 (1962)
Boullin, D. J.: The action of extracellular cations on the release of the sympathetic transmitter from peripheral nerves. J. Physiol. (Lond.) 189, 85–99 (1967)
Brown, G. L.: The release and fate of the transmitter liberated by adrenergic nerves. Proc. roy. Soc. B 162, 1–19 (1965)
Brown, G. L., Ferry, C. B.: Facilitation of output of sympathetic transmitter. J. Physiol. (Lond.) 167, 48p-49p (1963)
Brown, G. L., Gillespie, J. S.: Output of sympathetic transmitter from the spleen of the cat. J. Physiol. (Lond.) 138, 81–102 (1957)
Chang, C. C., Chiueh, C. C.: Modification of noradrenaline incorporation by nerve activities in the rat submaxillary gland. J. Physiol. (Lond.) 203, 145–157 (1969)
Davies, B. N., Withrington, P. G.: The release of noradrenaline by the sympathetic post-ganglionic nerves to the spleen of the cat in response to low frequency stimulation. Arch. int. Pharmacodyn. 171, 85–196 (1968)
Gillis, C. N.: Increased retention of exogenous norepinephrine by cat atria after electrical stimulation of the cardioaccelerator nerves. Biochem. Pharmacol. 12, 593–595 (1963)
Haefely, W., Hurlimann, A., Thoenen, H.: Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat. J. Physiol. (Lond.) 181, 48–58 (1965)
Hedqvist, P., Stjärne, L.: The relative role of recapture and of de novo synthesis for the maintenance of neuro-transmitter homeostasis in noradrenergic nerves. Acta physiol. scand. 76, 270–283 (1969)
Hughes, J.: Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Brit. J. Pharmacol. 44, 472–491 (1972)
Huković, S., Muscholl, E.: Die Noradrenalin-Abgabe aus dem isolierten Kaninchenherzen bei sympathischer Nervenreizung und ihre pharmakologische Beeinflussung. Naunyn-Schmiedebergs Arch. exp. path. Pharmak. 244, 81–96 (1962)
Kirpekar, S. M., Cervoni, P.: Effect of cocaine, phenoxybenzamine and phentolamine on catecholamine output from spleen and adrenal medulla. J. Pharmacol. exp. Ther. 142, 59–70 (1963)
Kirpekar, S. M., Furchgott, R. F., Wakade, A. R., Prat, J. C.: Inhibition by sympathomimetic amines of the release of norepinephrine evoked by nerve stimulation in the cat spleen. J. Pharmacol. exp. Ther. 187, 529–538 (1973)
Kirpekar, S. M., Misu, Y.: Release of noradrenaline by splenic nerve stimulation and its dependence on calcium. J. Physiol. (Lond.) 188, 219–234 (1967)
Kirpekar, S. M., Prat, J. C., Puig, M., Wakade, A. R.: Modification of the evoked release of noradrenaline from the perfused cat spleen by various ions and agents. J. Physiol. (Lond.) 221, 601–615 (1972)
Kirpekar, S. M., Puig, M.: Effect of flowstop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine. Brit. J. Pharmacol. 43, 359–369 (1971)
Löffelholz, K., Muscholl, E.: A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn-Schmiedebergs Arch. Pharmak. 265, 1–15 (1969)
Muscholl, E.: Cholinomimetic drugs and release of the adrenergic transmitter. In: Bayer Symposium II, New aspects of storage and release mechanisms of catecholamines. H. Schümann and G. Kroneberg, (eds.), pp. 168–186. Berlin-Heidelberg-New York. Springer 1970
Starke, K.: Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn-Schmiedeberg's Arch. Pharmakol. 274, 18–45 (1972a)
Starke, K.: Influence of extracellular noradrenaline on the stimulation-evoked secretion of noradrenaline from sympathetic nerves: Evidence for an α-receptor-mediated feedback inhibition of noradrenaline release. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 11–23 (1972b)
Steinsland, O. S., Furchgott, R. F., Kirpekar, S. M.: Inhibition of adrenergic neurotransmission by parasympathomimetics in the rabbit-ear artery. J. Pharmacol. exp. Ther. 184, 346–356 (1973)
Yamamoto, H., Kirpekar, S. M.: Effects of nerve stimulation on the uptake of norepinephrine by the perfused spleen of the cat. Europ. J. Pharmacol. 17, 25–33 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kirpekar, S.M., Prat, J.C. & Wakade, A.R. Effect of calcium on the relationship between frequency of stimulation and release of noradrenaline from the perfused spleen of the cat. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 205–212 (1975). https://doi.org/10.1007/BF00510451
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00510451